Angela Wagner, PhDAssociate Principal Scientist, Sterile & Specialty at Merck Sharpe & Dohme
Angela M. Wagner, Ph.D. is an Associate Principal Scientist in Sterile and Specialty Products at Merck Sharpe & Dohme (MSD), responsible for advancing formulation and manufacturing process development across MSD’s parenteral drug product portfolio from preclinical stages to Phase 3 development. Over her career, her research has spanned across a number of disease areas and drug modalities, including a focus in the discovery and development of specialty formulation, drug delivery, and manufacturing technologies for MSD’s oligonucleotide therapeutics pipeline. Dr. Wagner received her Ph.D. and M.S. in Chemical Engineering at the University of Texas at Austin (under the guidance of Prof. Nicholas Peppas), and received her B.S. in Chemical Engineering at the Pennsylvania State University.